What we do

In all of its locations HOYNG ROKH MONEGIER services the needs of clients in the field of intellectual property law, including patents and trade secrets, trademarks, copyrights and design rights, as well as in related fields, such as pharmaceutical regulatory law, unfair competition, media and advertising law and all IP related contracts.

Our services

Aerospace, automotive & marine

Biotechnology & Biologics

Chemicals

Electronics, computers, software & semiconductors

Pharmaceuticals

Industrial equipment & Manufacturing

Telecommunications & Networks

Retail & Consumer goods

Fashion & Luxury goods

Media

Medical devices

Arbitration & Mediation

CJEU & supreme court litigation

Copyright

Life sciences regulatory

Patents

Trademark & Design

Unfair competition & Trade secrets

IP Licensing & Transfer

01 Industries

02 Practices

Awards & Rankings

Case Studies

Website blocking orders in Europe

In 2012, HOYNG ROKH MONEGIER obtained the first website blocking order in the Netherlands on behalf of a number of movie studios (represented by anti-piracy organisation BREIN). On appeal, the order was suspended due to an incorrect application of the law by the court of appeal. The appellate court’s…

In 2012, HOYNG ROKH MONEGIER obtained the first website blocking order in the Netherlands…

ASML and Carl Zeiss SMT v. Nikon – immersion lithography

ASML Netherlands BV is the world’s largest manufacturer of lithography machines used in the production of computer chips. ASML’s high-tech lithography machines produce computer chips with nanometer precision (a nanometer is approximately 100,000 times thinner than a strand of human hair). ASML’s lithography machines, especially its most advanced ones…

ASML Netherlands BV is the world’s largest manufacturer of lithography machines used in the…

Lundbeck v. Tiefenbacher et al. – escitalopram

In 1972, the Danish pharmaceutical company H. Lundbeck A/S synthesised an organic compound known as citalopram. Citalopram was found to have a significant antidepressant effect as a selective serotonin reuptake inhibitor (SSRI). The new drug was launched by Lundbeck in 1989 under the brand name Cipramil® and was very…

In 1972, the Danish pharmaceutical company H. Lundbeck A/S synthesised an organic compound known…